96 related articles for article (PubMed ID: 8233655)
1. [What is the prognostic significance of histomorphology in small cell lung carcinoma?].
Facilone F; Cimmino A; Assennato G; Sardelli P; Colucci GA; Resta L
Pathologica; 1993; 85(1097):387-93. PubMed ID: 8233655
[TBL] [Abstract][Full Text] [Related]
2. [Pathological findings and prognosis in 202 patients with small cell lung cancer].
Huang ZY; Li HZ; Xu PQ
Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):38-41. PubMed ID: 2843333
[TBL] [Abstract][Full Text] [Related]
3. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
4. Clinical, histological and morphometrical parameters in small cell carcinoma of the lung: correlation with survival.
Sforza V; Santopietro R; Bindi M; Tucci E; Pirtoli L; Tosi P
Appl Pathol; 1986; 4(1-2):90-7. PubMed ID: 3034312
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between tumor histology and prognostic factors in lung cancer cases].
Kodama T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):45-53. PubMed ID: 2981517
[TBL] [Abstract][Full Text] [Related]
7. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.
Khan OA; Fitzgerald JJ; Field ML; Soomro I; Beggs FD; Morgan WE; Duffy JP
Ann Thorac Surg; 2004 Apr; 77(4):1173-8. PubMed ID: 15063229
[TBL] [Abstract][Full Text] [Related]
8. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
9. Staging in untreated patients with small cell lung cancer.
Vrdoljak E; Mise K; Sapunar D; Rozga A; Marusic M
Neoplasma; 2001; 48(2):154-6. PubMed ID: 11478698
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of angiogenesis in operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
[TBL] [Abstract][Full Text] [Related]
12. Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma.
Nakahara Y; Mochizuki Y; Miyamoto Y; Tanaka A; Kawamura T; Sasaki S; Nakahara Y; Katsura Y
Cancer; 2002 Jun; 94(11):3006-15. PubMed ID: 12115391
[TBL] [Abstract][Full Text] [Related]
13. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
14. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cytokinetic parameters in lung cancer after in vivo bromodeoxyuridine labelling.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Anticancer Res; 1999; 19(1A):531-4. PubMed ID: 10226593
[TBL] [Abstract][Full Text] [Related]
16. Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival.
Carney DN; Matthews MJ; Ihde DC; Bunn PA; Cohen MH; Makuch RW; Gazdar AF; Minna JD
J Natl Cancer Inst; 1980 Dec; 65(6):1225-30. PubMed ID: 6253711
[TBL] [Abstract][Full Text] [Related]
17. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
18. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
19. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of flow cytometry in non-small-cell lung cancer.
Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
